Trial intelligence / Profile preview

Bimatoprost in Men With Androgenic Alopecia

NCT01325337Phase 2Completed

Sponsor
Allergan
Start
Jun 2011
Primary completion
Aug 2012
Modality
Orthosteric Ligands
Countries
2
01

Overview

A Phase 2 trial of bimatoprost in androgenetic alopecia (AGA), sponsored by Allergan. Started Jun 2011; status: completed.

02

Drugs

bimatoprost
03

Conditions

androgenetic alopecia (AGA)

Beyond the preview

Go deeper on NCT01325337.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01325337.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call